Drugs Home > Generic Afinitor
At this time, patents prevent the manufacturing of a generic version of Afinitor (everolimus). The first patent is scheduled to expire in July 2016, which would be the earliest date that a generic version could become available. However, lawsuits or other patents for new uses of the drug could change this date.
Can I Buy Generic Afinitor?Afinitor® (everolimus) is a prescription medication that belongs to a group of drugs known as kinase inhibitors. It is approved to treat certain types of cancer and tumors. Specifically, Afinitor is approved for the treatment of:
- Advanced tumors of the pancreas
- Advanced kidney cancer after certain other medicines have been tried and failed
- A rare type of brain tumor or certain kidney tumors in people with a genetic condition known as tuberous sclerosis
- Certain types of advanced breast cancer in postmenopausal women who have not responded to certain other medications.